Get started
Author

Rachel T. Eguia

Observed names: Rachel Eguia, Rachel T Eguia
ORCID: 0000-0001-5772-1907
Observed ORCID: 0000-0001-5772-1907
OpenAlex ID: A5025754076
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
2020 · Allison J. Greaney, Tyler N. Starr, et al. · Cell Host & Microbe · 1,016
PDF
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
2020 · Katharine H.D. Crawford, Rachel Eguia, et al. · Viruses · 783
PDF
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
2020 · Katharine H D Crawford, Adam S Dingens, et al. · The Journal of Infectious Diseases · 265
PDF
A human coronavirus evolves antigenically to escape antibody immunity
2021 · Rachel Eguia, Katharine H. D. Crawford, et al. · PLoS Pathogens · 258
PDF
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
2019 · Juhye M. Lee, Rachel Eguia, et al. · eLife · 112
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein
2022 · M. Alejandra Tortorici, Alexandra C. Walls, et al. · Cell · 94
PDF
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
2020 · Adam S. Dingens, Katharine H. D. Crawford, et al. · Nature Communications · 68
PDF
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
2022 · Allison J. Greaney, Tyler N. Starr, et al. · PLoS Pathogens · 64
PDF
Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans
2019 · Y.Q. Shirleen Soh, Louise H. Moncla, et al. · eLife · 54
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin
2024 · Frances C. Welsh, Rachel T. Eguia, et al. · Cell Host & Microbe · 45
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
2022 · Ariana Ghez Farrell, Bernadeta Dadonaite, et al. · Viruses · 38
PDF
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
2022 · Allison J. Greaney, Rachel T. Eguia, et al. · PLoS Pathogens · 26
Comprehensive Profiling of Mutations to Influenza Virus PB2 That Confer Resistance to the Cap-Binding Inhibitor Pimodivir
2021 · Y.Q. Shirleen Soh, Keara D. Malone, et al. · Viruses · 21
PDF
Author response: Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
2019 · Juhye M Lee, Rachel Eguia, et al. · eLife · 4
Mutations to the HCoV-229E spike have counterbalancing effects on serum antibody neutralization and receptor binding
2026 · Sheri Harari, Rachel T Eguia, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays v2
2021 · Katharine H. D. Crawford, Rachel Eguia, et al. · 1
PDF
Pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays v1
2020 · Katharine H. D. Crawford, Rachel Eguia, et al. · 1
PDF
Author Reply to Peer Reviews of A human coronavirus evolves antigenically to escape antibody immunity
2021 · Jesse D. Bloom, Michael J. Boeckh, et al.
Author response: Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans
2019 · YQ Shirleen Soh, Louise H Moncla, et al. · eLife
Works count: 19
Citation count: 2,851
H-index: 13
I10-index: 13
Year
Topic
Type